EU Committee Backs Bristol, Astra Diabetes Drug Forxiga
AstraZeneca PLC and Bristol-Myers Squibb Co. should receive approval for diabetes drug Forxiga, European regulators said Friday, delivering a pleasant surprise for firms that were rebuffed by the U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article